@holoclara.bsky.social
📤 8
đź“Ą 2
đź“ť 14
In The Scientist’s Innovation Spotlight Q&A, our CEO Andrea Choe reveals how Holoclara is pioneering a new frontier in drug discovery by harnessing nature’s symbiotic species, starting with molecules derived from worms. 🪱💊 Read the full feature 👇
www.the-scientist.com/turning-worm...
loading . . .
Turning Worm-Derived Molecules into Life-Changing Therapies
Andrea Choe from Holoclara discusses her quest to develop novel drugs for chronic immune conditions by mining nature’s immunomodulators.
https://www.the-scientist.com/turning-worm-derived-molecules-into-life-changing-therapies-73106
5 months ago
0
0
0
Today we recognize the 1st World Eosinophilic Esophagitis (EoE) Day! We’re raising awareness and reaffirming our commitment to pioneering treatments for underserved patients through the therapeutic potential of worms! 🪱 Learn more:
www.holoclara.com
#NEAW
#EosAware
loading . . .
7 months ago
0
0
0
On AUTM on the Air, our CEO Andrea Choe shared insights on Holoclara’s work harnessing worm-derived molecules for medicine, along with her experiences collaborating with tech transfer offices at
@caltech.edu
and
@cornelluniversity.bsky.social
. 🎧 Listen now:
www.youtube.com/watch?v=TZIy...
loading . . .
Turning Worms Into Medicine: Dr. Andrea Choe on Innovation, Impact, and Tech Transfer
YouTube video by AUTM
https://www.youtube.com/watch?v=TZIyCGNqdLg
7 months ago
0
0
0
Worms were long overlooked—now they could help transform human health. 🪱 Our CEO Andrea Choe, shared the science behind our discovery engine and its potential to access other untapped sources with In Vivo Citeline. Read more 👇
tinyurl.com/4vr8sp96
loading . . .
Building The Worm Atlas For I&I Breakthroughs
The next big thing in auto-immune therapies: worms. Or so a young California biotech believes. Holoclara is pioneering a new class of medicines derived from intestinal worms to revolutionize the treat...
https://tinyurl.com/4vr8sp96
8 months ago
0
0
0
How might the “dark matter” of biology unlock new medicines? 🌌 Labiotech’s must-read explainer covers the rise of metabolomics as a critical tool for decoding biology, featuring insights from our CEO Andrea Choe. Check it out 👇
www.labiotech.eu/in-depth/met...
loading . . .
The metabolomics revolution: Why biotech leaders should pay attention
Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate biotech research.
https://www.labiotech.eu/in-depth/metabolomics-biotech/
8 months ago
0
0
0
In an
@asbmb.bsky.social
interview, CEO Andrea Choe shared how treating patients inspired her shift from medicine to entrepreneurship, founding Holoclara to bring relief to millions suffering from debilitating diseases – by harnessing molecules from worms. 🪱 Read more 👇
www.asbmb.org/asbmb-today/...
loading . . .
Biotech startup worms its way into therapeutics
Andrea Choe's company, Holoclara, has created an anti-inflammatory drug based on a molecule from worms.
https://www.asbmb.org/asbmb-today/industry/011725/biotech-startup-worms-its-way-into-therapeutics
9 months ago
0
3
2
Great to be featured in Labiotech’s Best in Biotech series! Check out their article to learn how we’re decoding biology through metabolomics to pioneer worm-derived therapies:
www.labiotech.eu/best-biotech...
loading . . .
Seven companies using metabolomics to decode biology
Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.
https://www.labiotech.eu/best-biotech/metabolomics-companies/
10 months ago
0
0
0
Great to see our CEO Andrea Choe on stage at Caltech's Merkin Institute Symposium where she shared insights from founding Holoclara amongst fellow entrepreneurs, scientists, and leaders.đź’ˇ
10 months ago
0
0
0
🎧On the latest @InVivoPodOnX episode, our CEO Andrea Choe discussed the incredible therapeutic potential of gut-dwelling roundworms and Holoclara's work harnessing worm-derived molecules to treat devastating disorders. Tune in now 👇
youtu.be/dJluLzQ67K4?...
loading . . .
Ep. 16 | In Vivo with Dr. Andrea Choe On The Gut Worm Revolution
YouTube video by In Vivo Podcast
https://youtu.be/dJluLzQ67K4?feature=shared
11 months ago
0
0
0
We’re pleased to announce our first-in-human Phase 1 clinical trial of HC002 – a novel worm-derived medicine – and eosinophilic esophagitis (EoE) as our lead indication. Check out our video and press releases below for more on HC002 and EoE ⬇️
loading . . .
12 months ago
1
0
0
you reached the end!!
feeds!
log in
